Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Immunology and Microbiology
Infectious Disease
100%
Infection
100%
Cryptococcus gattii
88%
Cryptococcus neoformans
84%
Multilocus Sequence Typing
65%
Antifungal Susceptibility
56%
Genetic Variability
51%
Human immunodeficiency virus
43%
Peptides
41%
Serotype
40%
Candida
40%
Infectious Agent
39%
Filobasidiella
39%
Candida albicans
37%
Minimum Inhibitory Concentration
31%
Antimicrobial Peptides
30%
Cohort Effect
27%
Biofilm
27%
Meningitis
26%
Susceptibility
24%
Antifungal Activity
24%
Candida parapsilosis
23%
Epidemiology
22%
Molecular Epidemiology
21%
Candida Auris
19%
Cladistics
19%
Aspergillosis
17%
Antifungal Resistance
16%
Wild Type
16%
In Vitro
15%
Aspergillus fumigatus
13%
Galleria mellonella
13%
Antigen
12%
Whole Genome Sequencing
12%
Microorganism
11%
Matrix-Assisted Laser Desorption-Ionization
11%
Time-of-Flight Mass Spectrometry
11%
Systemic Lupus Erythematosus
11%
Systemic Scleroderma
11%
Streptococcus pneumonia
11%
MIC50
10%
Antimicrobial Agent
9%
Mortality Rate
9%
Immune System
8%
Filamentous Fungus
8%
Human Pathogen
7%
Immunocompromised Patient
7%
Acquired Immune Deficiency Syndrome
7%
Restriction Fragment Length Polymorphism
7%
Prevalence
7%
Keyphrases
Colombia
43%
Cryptococcosis
42%
Gattii
37%
Antifungal Susceptibility
36%
Cryptococcus Neoformans
33%
Cryptococcus Gattii
32%
Molecular Subtypes
30%
Candida Albicans (C. albicans)
29%
Neoformans
27%
Core Genome multilocus Sequence Typing (cgMLST)
26%
Cryptococcus
26%
Candida Auris
23%
Candida Species
23%
Antimicrobial Peptides
22%
Genetic Diversity
17%
Genotypic Diversity
17%
Priority Pathogens
17%
Candida Parapsilosis
17%
Aurès
16%
Voriconazole
15%
Murine Model
15%
Virulent Strain
14%
Pore-forming Peptide
14%
Epidemiology
14%
Cryptococcus Gattii Species Complex
14%
Aspergillus Fumigatus
13%
Molecular Epidemiology
13%
Genotype
13%
C.albicans
12%
Biofilm
12%
Cryptococcus Species
12%
Veterinary Isolates
11%
Resistant Isolate
11%
Serotype C
11%
Mutation Profile
11%
Cyp51A Gene
11%
Limited Systemic Sclerosis
11%
Systemic Lupus Erythematosus
11%
World Health Organization
11%
Fatal Case
11%
Epidemiological Cut-off Values
11%
MIC Distribution
11%
Rezafungin
11%
Fosmanogepix
11%
Ibrexafungerp
11%
Azole Resistance
11%
Sequence Type
11%
C. Parapsilosis
11%
Fluconazole
10%
Highly Virulent
10%